Erminio A. Bonizzoni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 29, 2025
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting.
Journal: Future oncology (London, England)
Published: August 09, 2025
NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of Chemotherapy: A Phase II Clinical Trial.
Journal: Cancer medicine
Published: October 23, 2024
Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy.
Journal: JAMA neurology
Published: March 18, 2024
Evaluation of a digital tool supporting therapeutic decision making for the personalized management of patients with type 2 diabetes not treated with insulin: A pilot study.
Journal: Diabetes research and clinical practice
Published: May 16, 2023
Proposal for reference values for the developmental effects of valproate based on human data using a benchmark dose approach.
Journal: Regulatory toxicology and pharmacology : RTP
Published: October 17, 2022
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
Journal: Scientific reports
Published: October 10, 2022
Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis: a combined analysis.
Journal: Future oncology (London, England)
Published: August 26, 2022
Efficacy of Safinamide and Gender Differences During Routine Clinical Practice.
Journal: Frontiers in neurology
Published: August 10, 2021
Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial.
Journal: Diabetes research and clinical practice
Published: July 04, 2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis.
Journal: Future oncology (London, England)
Published: April 21, 2021
Last Updated: 09/26/2026